AIMMUNE THERAPEUTICS INC's ticker is AIMT and the CUSIP is 00900T107. A total of 156 filers reported holding AIMMUNE THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.54 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $68,000 | +88.9% | 2,000 | -8.9% | 0.00% | – |
| Q2 2020 | $36,000 | -53.8% | 2,195 | -6.1% | 0.00% | – |
| Q1 2020 | $78,000 | 0.0% | 2,337 | 0.0% | 0.00% | – |
| Q4 2019 | $78,000 | +62.5% | 2,337 | 0.0% | 0.00% | – |
| Q3 2019 | $48,000 | +17.1% | 2,337 | +17.4% | 0.00% | – |
| Q2 2019 | $41,000 | +10.8% | 1,990 | +19.7% | 0.00% | – |
| Q1 2019 | $37,000 | -94.4% | 1,662 | -90.5% | 0.00% | -100.0% |
| Q1 2018 | $661,000 | 0.0% | 17,481 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $661,000 | – | 17,481 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|